Want to join the conversation?
$ZBH experienced modestly negative pricing pressure consistent with prior expectations. The resulting price decline in 3Q15 was 2.1%. $ZBH accelerated revenue growth in several geographies and product categories. Asia-Pacific delivered 4.7% growth and sales grew by 1.7% in the Europe, Middle East and Africa region. Americas revenue fell by 0.7%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?